An anti-inflammatory and anti-fibrotic proprietary chinese medicine nasal spray designated as allergic rhinitis nose drops (arnd) with potential to prevent sars-cov-2 coronavirus infection by targeting rbd (delta)- angiotensin converting enzyme 2 (ace2) binding

HIGHLIGHTS

• who: Ka Man Yip from the Department of Biology, Faculty of Science, Hong Kong Baptist University, Kowloon Tong, Hong Kong, Special Administrative Region, China have published the paper: An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding, in the Journal: (JOURNAL) of January/18,/2022
• what: The above in silico and in_vitro results support that the proprietary Chinese medicine nasal spray ARND acts as an antiviral hygienic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.